Intensive Tutored Training to become an International Expert in the Design of Preclinical and Clinical Studies on Cancer Immunotherapy.
Objectives
The
main objective of the tutorial is to train
professionals from preclinical, clinical or management
areas in the design
of Cancer Immunotherapy studies in order they can become international
experts in this field.
Likewise,
the participants will perform it on
an intensive online working days.
They will have a personalized tutoring in order to
get a training as
useful as possible.
International Tutorial on Cancer Immunotherapy Research Design
The different modalities of Cancer Immunotherapy wether cellular, monoclonal antibodies, different vaccine modalities or oncolytic viruses have changed the traditional diagnostic-therapeutic approach in many of our cancer patients.
At the same time, there has been a progressively increasing change in the design of cancer immunotherapy studies, In order to optimize the benefit of our patients in the shortest period of time the preclinical level, in-vitro or animal models, and at the clinical level, to try to benefit our patients in their different phases of development.
The final success of a given research study depends on the appropriate design of methods, objectives and real implementation of the clinical the preclinical study, and whether it can later be replicated or its application generalized to all our patients.
Thus arises the need to bring together the best worldwide experts and trainers in this International Tutorial on Cancer Immunotherapy Research Studies Design.
Six intensive online working days
From 22nd to 26th November, 2021. The
Tutorial will be developed in 6 intensive online working days consisting on:
•Master
Lecture on
Advanced Concepts of Cancer
Immunotherapy Studies Design
(Overall design, hypothesis, primary objectives, secondary
objective, material and methods, statistical analysis,
feasibility-opportunity).
•Analysis
in small groups by sections of the design of the investigators' draft.
•Individualized
analysis by draft
sections with
the expert
trainer.
•Lessons
of the day.
Summary by the trainers of the most representative changes introduced in the
corresponding draft
section.
•“Old
Stories from my research experience". Informal
discussion of ocurrences
illustrating some
of the key aspects of Cancer
immunotherapy research.
•Final
protocols presentation and awards ceremony (day 6).
Days 1 to 5: From 7:00 a.m. to 20:00 p.m. (CEST)
Day
6: From
7:00 a.m.
to 14:00 p.m. (CEST)
Admission process
1. Candidate profile graduate in a biosanitary career, professional in the clinical or
preclinical area or pharmaindustry professional will be considered as a candidate . A
maximum of 36 candidates (6 groups of 6 candidates) will be admitted to the tutorial
2. Submission documentation period: From 15th March to 15th July, 2021 . Candidates
will send to tideio@hmhospitales.com the following documentation:
• A draft of a preclinical or clinical cancer immunotherapy proposal for a
research study, they will develop during their training stay (online).
• An updated CV (
• A personal letter of introduction (English)
3. Staff evaluation: The Director and the TiDeIO expert trainers will evaluate:
• Draft, research project (1 10 points)
• CV and letter of recommendation (1 10 points)
4. Communication of admission : Researchers will be informed of the result of their
admission process before 1 st September
211018_tutorial (1).pdf
211122_tutorial _Explicative_Document_candidates (1).pdf